Pilot Study of Vedic Medicine for Type 2 Diabetes
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.
Full description
Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.
Sex
Ages
Volunteers
Inclusion criteria
- Kaiser Permanente members
- Newly diagnosed type 2 Diabetes
- Baseline glycosylated hemoglobin level of 6.0-7.9.
Exclusion criteria
- Pregnancy or nursing mother
- Currently taking warfarin
- Diagnosis of psychotic disorder or recent hospitalization for depression
- Unable to comply with or attend treatment sessions
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal